Finance

Beta
Lists
301230:SHE
PharmaResources (Shanghai) Co Ltd
CNÂ¥33.34
+1.86%
(+0.61) 1D
Jun 10, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301230...
Open
CNÂ¥32.51
High
CNÂ¥34.00
Low
CNÂ¥32.06
Mkt. cap
4.49B
Avg. vol.
6.75M
Volume
4.54M
P/E ratio
102.27
52-wk high
CNÂ¥67.97
52-wk low
CNÂ¥28.90
EPS
CNÂ¥0.33
Shares outstanding
139.59M
No. of employees
1K
Open
CNÂ¥32.51
High
CNÂ¥34.00
Low
CNÂ¥32.06
Mkt. cap
4.49B
Avg. vol.
6.75M
Volume
4.54M
P/E ratio
102.27
52-wk high
CNÂ¥67.97
52-wk low
CNÂ¥28.90
EPS
CNÂ¥0.33
Shares outstanding
139.59M
No. of employees
1K
News stories
From sources across the web
About PharmaResources (Shanghai) Co Ltd
CEO-
Employees1.16K
FoundedDec 14, 2007
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
183.31M
161.66M
173.95M
172.29M
Cost of goods sold
135.42M
113.37M
141.40M
117.29M
Cost of revenue
135.42M
113.37M
141.40M
117.29M
Research and development expenses
10.27M
9.80M
8.36M
10.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.33M
26.90M
31.02M
27.59M
Operating expense
37.72M
37.54M
41.00M
38.16M
Total operating expenses
173.14M
150.91M
182.40M
155.45M
Operating income
10.16M
10.75M
-8.45M
16.83M
Other non operating income
-1.40M
1.57M
-1.69M
-2.12M
EBT including unusual items
11.62M
9.15M
-3.51M
25.98M
EBT excluding unusual items
9.18M
8.67M
-11.07M
19.90M
Income tax expense
-1.17M
-840.10K
-3.05M
2.21M
Effective tax rate
-10.07%
-9.18%
87.04%
8.49%
Other operating expenses
65.06K
896.06K
306.17K
327.40K
Net income
12.79M
9.99M
-454.81K
23.78M
Net profit margin
6.98%
6.18%
-0.26%
13.80%
Earnings per share
-
-
-
-
Interest and investment income
623.61K
288.09K
177.60K
7.10M
Interest expense
-2.10M
-2.04M
-1.98M
-1.91M
Net interest expenses
-1.47M
-1.75M
-1.80M
5.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.12M
17.23M
-1.39M
23.90M
Gain or loss from assets sale
-
-
-41.52K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more